Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2003 Mar;47(3):1177. doi: 10.1128/AAC.47.3.1177.2003

env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors

Valery Fikkert 1, Peter Cherepanov 1, Kristel Van Laethem 1, Anke Hantson 1, Barbara Van Remoortel 1, Christophe Pannecouque 1, Erik De Clercq 1, Zeger Debyser 1, Anne-Mieke Vandamme 1, Myriam Witvrouw 1
PMCID: PMC149344

Volume 46, no. 12, p. 3954-3962. Page 3955: Position numbering throughout corresponds to HIV-1 (LAV-1) recombinant clone pNL4.3 (GenBank accession no. M19921).

Page 3958, column 2, lines 3 and 4: “the same sequences in the respective HIV-1 NL4.3 strains selected in vitro were observed” should read “the same env sequences were observed as those in the respective in vitro-selected HIV-1 NL4.3 strains.”

Page 3961, column 1, lines 29 and 30: “selection of CCR5-using strains” should read “selection toward CCR5-using strains.”


Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES